Investors often have their own theories when it comes to choosing a stock but most experts believe that tracking stocks that are gaining momentum is a good idea. Among the stocks that have gained momentum recently, investors could consider tracking the KemPharm Inc (NASDAQ: KMPH) stock.
The stock has gained momentum even though there has been no recent news with regards to the company’s business. In that situation, it could be wise to perhaps take a look at some key developments from the past. In December last year, the company announced that it had a meeting with the United States Food and Drug Administration with regards to the New Drug Application for its product KP 415.
The product in question is meant for treating attention deficit hyperactivity disorder. It should be noted that the FDA did not raise any red flags regarding KP 415. It could be one of the reasons behind the optimism around the KemPharm stock at this point.
Writing for business and finance publishers has become his passion over the last decades after he completed a master’s degree in Financial Management. Sharing some opinions and forecasts to thousands of readers is a routine job for him but he never promises to invest in one stock.